Hims & Hers Swings to a $33 Million Third-Quarter Loss as Gross Margin Falls to 57% After Its Shift to Branded Weight-Loss Drugs
Hims & Hers reported third-quarter revenue of $890.4 million, up 49%, with 2.79 million subscribers, up 13%, but a net loss of $33.0 million compared with net income of $15.8 million a year earlier, as gross margin fell from 74% to 57%. The company narrowed its 2026 revenue forecast to $3.13 billion to $3.15 billion and lowered its adjusted EBITDA range; it said its U.S. weight-loss business has shifted toward branded GLP-1 access, with compounded GLP-1s offered on a limited scale.